Frédéric Vallot
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
- Neutropenia and Cancer Infections
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Respiratory Support and Mechanisms 4
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 2
- Oncology 7
- Lung Cancer Research Studies 4
- Co-authors
- Elizabeth Steels (7 shared papers)Thierry Berghmans (8 shared papers)Fabrice Branle (6 shared papers)Jean‐Paul Sculier (7 shared papers)J.J. Lafitte (4 shared papers)Marianne Paesmans (6 shared papers)Anne‐Pascale Meert (4 shared papers)F. Lemaı̂tre (5 shared papers)
In The Last Decade
Frédéric Vallot
15 papers receiving 615 citations
Peers
Comparison fields: 5 of 67
- Oncology 276
- Pulmonary and Respiratory Medicine 209
- Cancer Research 86
- Molecular Biology 210
- Hepatology 13
Countries citing papers authored by Frédéric Vallot
This map shows the geographic impact of Frédéric Vallot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Vallot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Vallot more than expected).
Fields of papers citing papers by Frédéric Vallot
This network shows the impact of papers produced by Frédéric Vallot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Vallot. The network helps show where Frédéric Vallot may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Vallot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 353 | |
| 2 | 2003 | 140 | |
| 3 | 2002 | 66 | |
| 4 | 2001 | 29 | |
| 5 | 2003 | 18 | |
| 6 | 2001 | 14 | |
| 7 | 2001 | 13 | |
| 8 | [The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers]. | 2001 | 4 |
| 9 | 2023 | 4 | |
| 10 | 2022 | 3 | |
| 11 | 1999 | 2 | |
| 12 | 2017 | 1 | |
| 13 | 2023 | 1 | |
| 14 | 2019 | 1 | |
| 15 | [Mechanical ventilation in the cancer patient]. | 2001 | 1 |
| 16 | [ACE-inhibition and bradykinin-mediated angioedema]. | 2020 | 1 |
| 17 | La ventilation artificielle chez les patients atteints de cancer | 2008 | 0 |
| 18 | 2000 | 0 |
About Frédéric Vallot
Frédéric Vallot is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine, having authored 18 papers that have together received 651 indexed citations. Recurring topics across this work include Respiratory Support and Mechanisms (4 papers), Lung Cancer Research Studies (4 papers), Cancer therapeutics and mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cardiac tumors and thrombi (2 papers), Cardiac Structural Anomalies and Repair (2 papers), Lung Cancer Diagnosis and Treatment (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Oncology (276 citations), Pulmonary and Respiratory Medicine (209 citations), Cancer Research (86 citations), Molecular Biology (210 citations) and Hepatology (13 citations). Frédéric Vallot has collaborated with scholars based in Belgium and France. Frequent co-authors include Elizabeth Steels, Thierry Berghmans, Fabrice Branle, Jean‐Paul Sculier, J.J. Lafitte, Marianne Paesmans, Anne‐Pascale Meert, F. Lemaı̂tre, Céline Mascaux and Sculier Jp. Their work appears in journals such as Supportive Care in Cancer, British Journal of Cancer, European Journal of Cancer, European Respiratory Journal and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.